Navigation Links
Facet Solutions Completes Facet Joint and Disc Replacement Study
Date:10/8/2008

HOPKINTON, Mass., Oct. 8 /PRNewswire/ -- Facet Solutions, Inc. today announced the successful completion of a scientific evaluation for a total joint reconstruction in the lumbar spine by Dr. Vijay Goel's laboratory at the University of Toledo. The study evaluated the combination of Facet Solutions' ACADIA(TM) Facet Replacement System (AFRS(TM)) with a semi-constrained disc replacement device and then, separately, with a polymeric disc replacement device in a finite element model. The results demonstrated restoration of the biomechanics of the native spine. Dr. Goel commented, "The FEA model demonstrates the ability of the ACADIA(TM) technology in combination with different disc replacement technologies to mimic the biomechanics of the intact spine." Marc Peterman, Vice President of R&D for Facet Solutions added, "This study leverages our landmark intellectual property in combining facet replacement with an anterior disc, and it provides further evidence that our anatomic facet design will work with a variety of anterior motion-sparing devices." The details of this study will be presented by Dr. Goel at 11:45am on Tuesday, October 14th at the NASS pre-meeting course in Toronto, Ontario.

Facet Solutions, Inc. has developed the ACADIA(TM) Facet Replacement System (AFRS(TM)) to provide patients with lumbar spinal stenosis and facet degeneration a motion preserving alternative to lumbar spinal fusion. The AFRS(TM) procedure includes replacement of the diseased facet joint with an anatomic implant that restores the natural motion, stability, and balance to the lumbar spine.

*Note: ACADIA(TM) is an investigational device in the United States. It is limited by United States (U.S.) Federal Law for investigational use only.

About Facet Solutions

Facet Solutions, Inc. is a privately held, venture-backed company focused on development and commercialization of surgical devices for the treatment of facet-related spinal disorders. Facet Solution
'/>"/>

SOURCE Facet Solutions
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. US Facet Fixation Market to Increase by Over 60% Annually Through 2012
2. Facet Solutions Establishes Corporate Headquarters and Expands Executive Team
3. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
4. Vital Images Releases Next Generation Enterprise-Wide Solutions Featuring Vitrea(R) 4.0 and ViTALConnect(R) 4.1
5. Haemonetics Announces New Subsidiary, Haemonetics Software Solutions
6. BioLife Solutions Expands Scientific Advisory Board
7. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions
8. Elekta Displays Complete Volumetric Intensity Modulated Arc Therapy Solutions at ESTRO
9. Total Site Solutions Selected to Provide Construction Management Services for Existing Pharmaceutical and Biotech Customer for Data Center Expansion Project
10. BioLife Solutions CryoStor(TM) Adopted by Tissue Regeneration Therapeutics for Preservation Protocol for New, Non-Embryonic Source of Stem Cells
11. Cooler Solutions and Leading Research Hospital to Design Revolutionary Osteoporosis Diagnosis Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... DUBLIN , Mar. 04, 2015 Research ... announced the addition of the "Global Biologics ... their offering. , The Global ... professional and in-depth study on the current state ... The report provides a basic overview of the ...
(Date:3/4/2015)... March 04, 2015 Proove ... Personalized Medicine, is excited to announce the launch ... to Optimize the Management of Pain”. , The ... Medscape.com for the next year. The focus of ... to recognize inadequate pain treatments, integrate appropriate pain ...
(Date:3/4/2015)... 2015 Vegalab announced the acquisition of Ecowin, ... year. As part of the acquisition, Ecowin rebranded itself ... his role as CEO for the company,s Korea operations. ... work alongside Koo and oversee developments at the new ... Koo founded Ecowin in 2008 to ...
(Date:3/4/2015)... PARIS , March 4, 2015 ... Hopitaux de Paris en ... «   SARAH   », qui compare   ... l,yttrium-90 avec le   sorafénib dans le carcinome ... atteints d,un cancer du foie avancé   ; ...
Breaking Biology Technology:Global Biologics and Biosimilars Industry Report 2015-2020 2Proove Biosciences Launches CME Accredited Program with Medscape 2Proove Biosciences Launches CME Accredited Program with Medscape 3Korean Government Program Supports Vegalab's Research and Development 2Korean Government Program Supports Vegalab's Research and Development 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 2Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 4Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 5Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 6
... BALTIMORE, Sept. 13 Champions Biotechnology, Inc. (OTC Bulletin Board: ... of advanced preclinical platforms and tumor specific data to enhance ... for the fiscal 2011 first quarter ended July 31, 2010. ... in the Company,s Form 10-Q at www.championsbiotechnology.com . ...
... Berkeley Engineers at the University of California, Berkeley, ... that could one day give new meaning to the ... a material that functions like the human skin, which ... said Ali Javey, associate professor of electrical engineering and ...
... Corporation Reports First Quarter Fiscal 2011 Financial Results. Revenue Increases 23.8% to RMB71.7 ... ET September 10, 2010." /> China Cord Blood Corporation Reports First ... ... ...
Cached Biology Technology:Champions Biotechnology Reports Fiscal 2011 First Quarter Financial Results 2Champions Biotechnology Reports Fiscal 2011 First Quarter Financial Results 3Champions Biotechnology Reports Fiscal 2011 First Quarter Financial Results 4Engineers make artificial skin out of nanowires 2Engineers make artificial skin out of nanowires 3China Cord Blood Corporation Reports First Quarter Fiscal 2011 Financial Results 2China Cord Blood Corporation Reports First Quarter Fiscal 2011 Financial Results 3China Cord Blood Corporation Reports First Quarter Fiscal 2011 Financial Results 4China Cord Blood Corporation Reports First Quarter Fiscal 2011 Financial Results 5China Cord Blood Corporation Reports First Quarter Fiscal 2011 Financial Results 6China Cord Blood Corporation Reports First Quarter Fiscal 2011 Financial Results 7China Cord Blood Corporation Reports First Quarter Fiscal 2011 Financial Results 8China Cord Blood Corporation Reports First Quarter Fiscal 2011 Financial Results 9China Cord Blood Corporation Reports First Quarter Fiscal 2011 Financial Results 10China Cord Blood Corporation Reports First Quarter Fiscal 2011 Financial Results 11China Cord Blood Corporation Reports First Quarter Fiscal 2011 Financial Results 12
(Date:2/5/2015)... RESEARCH TRIANGLE PARK, North Carolina , ... in sein 35. Jahr als spezialisiertes Logistikunternehmen ... seine Position als einzige klinische Logistikfirma (Clinical ... soll. Die Kernbotschaft der neuen Kampagne lautet ... Protokollen und Lieferungen. Foto: ...
(Date:2/5/2015)... January 28, 2015 New Market ... And Segment Forecasts To 2020 has Been Added to ... market is expected to reach USD 5.10 billion by ... Research, Inc. IR cameras help identify the site of ... to witness surging demand in medical imaging applications. They ...
(Date:1/22/2015)... ( http://www.researchandmarkets.com/research/4trb7t/biometrics_a ) has announced the addition of ... to their offering. , The primary goal ... who she/he is claiming to be, and for this purpose, ... characteristics, such as fingerprint, hand or palm print, iris, face ...
Breaking Biology News(10 mins):Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3
... Speedy diagnosis of the temper and vital signs of ... humanity, says a distinguished partnership of international scientists urging ... 10 years. The Partnership for Observation of the ... are among profound concerns that must be better measured ...
... found that the children of mothers whose water supplies ... expression changes that may lead to cancer and other ... potential harmful effects of these prenatal exposures, the new ... to detect signs of arsenic contamination. This is ...
... Company Anticipates Acquisition Could More Than Double its Current ... the Medical and Healthcare Industry, SAN JOSE, Calif., ... a leading biometric and security,solutions provider, announced today the ... Medical Systems (OTC: CHSY), a company listed in,the US ...
Cached Biology News:Human safety, prosperity depend on better ocean observing system: Scientists 2Human safety, prosperity depend on better ocean observing system: Scientists 3Human safety, prosperity depend on better ocean observing system: Scientists 4Human safety, prosperity depend on better ocean observing system: Scientists 5Human safety, prosperity depend on better ocean observing system: Scientists 6Human safety, prosperity depend on better ocean observing system: Scientists 7Human safety, prosperity depend on better ocean observing system: Scientists 8MIT: Prenatal arsenic exposure detected in newborns 2MIT: Prenatal arsenic exposure detected in newborns 3Titanium Group Signs Letter of Intent to Acquire Multimilion Dollar Medical Software Company and Its Existing Sales Network 2Titanium Group Signs Letter of Intent to Acquire Multimilion Dollar Medical Software Company and Its Existing Sales Network 3Titanium Group Signs Letter of Intent to Acquire Multimilion Dollar Medical Software Company and Its Existing Sales Network 4